Markus J. Cappel
2019
In 2019, Markus J. Cappel earned a total compensation of $1.3M as Chief Business Officer at ChemoCentryx.
Compensation breakdown
| Non-Equity Incentive Plan | $134,499 |
|---|---|
| Option Awards | $487,473 |
| Salary | $426,981 |
| Stock Awards | $220,400 |
| Other | $2,322 |
| Total | $1,271,675 |
Cappel received $487.5K in option awards, accounting for 38% of the total pay in 2019.
Cappel also received $134.5K in non-equity incentive plan, $427K in salary, $220.4K in stock awards and $2.3K in other compensation.
Rankings
In 2019, Markus J. Cappel's compensation ranked 8,132nd out of 13,971 executives tracked by ExecPay. In other words, Cappel earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,132 out of 13,971 | 42nd |
Division Manufacturing | 3,211 out of 5,701 | 44th |
Major group Chemicals And Allied Products | 1,219 out of 2,200 | 45th |
Industry group Drugs | 1,038 out of 1,886 | 45th |
Industry Pharmaceutical Preparations | 772 out of 1,398 | 45th |
Source: SEC filing on April 5, 2022.
Cappel's colleagues
We found two more compensation records of executives who worked with Markus J. Cappel at ChemoCentryx in 2019.